Brief: Aptose Biosciences Inc Files Prospectus Related To Resale Of Up To 12 Million Common Shares By Selling Stockholders- SEC Filing
13/02/2025 23:16
Aptose Biosciences Inc APS.TO :
* APTOSE BIOSCIENCES INC FILES PROSPECTUS RELATED TO RESALE
OF UP
TO 12 MILLION COMMON SHARES BY SELLING STOCKHOLDERS- SEC FILING
Source text: ID:n0001193125-25-026207
Further company coverage: APS.TO
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting